Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.The Journal of Pharmacology and Experimental Therapeutics|July 21, 2007
Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 miceMargi E Goldstein, Yang Cao, Tracey Fiedler, et al.The Journal of Pharmacology and Experimental Therapeutics|September 8, 2021
A Glutamate N-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical UseScott J Myers, Kamalesh P Ruppa, Lawrence J Wilson, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligandsArgyrios G Arvanitis, Joseph T Rescinito, Charles R Arnold, et al.Journal of Medicinal Chemistry|September 3, 2004
Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonistsRichard A Hartz, Kausik K Nanda, Charles L Ingalls, et al.Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent gamma-secretase inhibitorsMichael G Yang, Jian-Liang Shi, Dilip P Modi, et al.Neuropharmacology|November 3, 2015
Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancyYu-Wen Li, Matthew A Seager, Trevor Wojcik, et al.Nuclear Medicine and Biology|May 6, 2014
Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptorsNicholas J Lodge, Yu-Wen Li, Frederick T Chin, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligandsArgyrios G Arvanitis, Joseph T Rescinito, Charles R Arnold, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SARChristiana Iwuagwu, Dalton King, Ivar M McDonald, et al.Pageof 4